3rd Quarter - Report

GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2113-Prescription Drug STAR Act of 2019;H.R. 2296-More Efficient Tools to Realize Information for Consumers (METRIC) Act;S. 1895-Lower Health Care Costs ActSection 306;S. 2543-The Prescription Drug Pricing Reduction Act (PDPRA) of 2019; H.R. 3-Lower Drug Costs Now Act of 2019 relating to pharmacy DIR.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 2296 (116th), H.R. 3 (116th), H.R. 2113 (116th), S. 1895 (116th)

Medicare/Medicaid MMM

General issues relating to PBM point of sale rebates, spread pricing and price transparency.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.